Duloxetine Capsule, Delayed Release
Product Images NDC 47335-381

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 47335-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-duloxetine-figure1 (Spl Duloxetine Figure1)

The text shows a chart that displays the proportion of patients with relapse over time from randomization to relapse for a certain treatment. The chart shows values for the number of patients with relapse in intervals of days, and also shows the treatment given to these patients. The treatment is not discernible from the given text.*

FDA Label Image

Spl Duloxetine Figure10

The text describes a graph or chart showing the percentage improvement in pain from a baseline measurement for a treatment called Duloxetine compared to a placebo. The treatment is taken once daily at a dosage of either 60mg or 120mg. The graph also shows various percentages of improvement on the y-axis, ranging from 0 to 100 and various time points on the x-axis ranging from 10 to 200.*

FDA Label Image

Spl-duloxetine-figure2 (Spl Duloxetine Figure2)

This appears to be a graph depicting the proportion of patients with relapse over time from randomization in a clinical trial comparing a placebo treatment to a treatment with Duloxetine. The X-axis represents the time from randomization to relapse (in days) and the Y-axis represents the proportion of patients experiencing relapse. The data is presented as line graphs for the two treatments, with the Duloxetine line showing a lower proportion of patients experiencing relapse over time compared to the placebo line.*

FDA Label Image

Spl-duloxetine-figure3 (Spl Duloxetine Figure3)

The text is describing a graph showing the percentage of patients who improved based on their pain levels from baseline. The graph shows different levels of improvement ranging from 0% to 100%. Unfortunately, there is not enough information to provide a more specific description.*

FDA Label Image

Spl-duloxetine-figure4 (Spl Duloxetine Figure4)

FDA Label Image

Spl-duloxetine-figure5 (Spl Duloxetine Figure5)

FDA Label Image

Spl-duloxetine-figure6 (Spl Duloxetine Figure6)

FDA Label Image

Spl Duloxetine Figure8

This appears to be a table showing the percentage improvement in pain from baseline for a placebo and Duloxetine 60/120 mg once daily. The top row may indicate the percentage of patents improved.*

FDA Label Image

Spl Duloxetine Figure9

The text appears to be a graph showing the percentage of patients improved in pain from baseline. The graph illustrates the percentage on the y-axis and the different treatments (Placebo and Duloxetine 60mg) on the x-axis. The title of the graph is "Percentage of Patients Improved" with further information given as "in Pain from Baseline (80CF)".*

FDA Label Image

Spl-duloxetine-lable-20mg (Spl Duloxetine Lable 20mg)

This appears to be a prescription medication called Duloxetine Delayed-Release Capsules USP. The label states that it is important to dispense with a Medication Guide for each patient. The product code number is DG 47335.381-86.*

FDA Label Image

Spl-duloxetine-lable-30mg (Spl Duloxetine Lable 30mg)

This is a label for Duloxetine Delayed-Release Capsules with National Drug Code (NDC) 47335-382-83, containing 30 capsules. The pharmacist is instructed to dispense with the Medication Guide to each patient, and it is only available by prescription (Rx only). The rest of the label seems to be alphanumeric codes and not readable.*

FDA Label Image

Spl-duloxetine-lable-60mg (Spl Duloxetine Lable 60mg)

This is a medication guide for Taen delayed-release capsules containing duloxetine hydrochloride USP distributed by Sun Pharmaceutical Industries, Inc. The capsules are manufactured in Gujarat, India and each capsule contains 67.3mg of duloxetine equivalent to 60mg. The usual dosage is not provided, and it is important to note that the capsules should not be used if the inner seal is missing. The medication guide is available at https://www.sunpharma.com/usa/products for prescription only.*

FDA Label Image

Spl-duloxetine-structure (Spl Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.